I was getting excited about new data I found. In addition to comparing GDP per capita data between the US and Africa, I also found average ARV drug prices, some data of production costs, and drug company profits. My idea was to use comparisons between GDP to set up a pricing structure. The problem lies in the complexities of the AIDS drugs cocktails. Some of the pills are monopolistic, some can be purchased as generics, some are available in the US but not in Africa, and some are available in Africa but not the US. So just as I was getting excited about having data to go along with my theory, it turns out my paper is going to be almost pure theory.
But all is not lost, I got a lot of work done tonight (its 5 AM), and I am liking the direction the paper is taking.
PS does anyone want to work on Econometrics tommorrow?
PSS do you guys still read this now that you are done with your papers?
Will
Powered by FireStats
I still read your blogs Will, don’t worry. I feel for ya, keep up the good fight.
Perhaps the number per 100,000 of individuals with HIV in certain African nations compared with the occurrence in the United States could give you an general figure for the ratio of percent demanded in the two regions. Then again, data may make this an extremely depressing research project. Just tell us what we want to hear: AIDs is never going to be a problem in our lifetime…right?